Watchlist Price Alert

Provention Bio Inc. (PRVB)

NASDAQ: PRVB · Real-Time Price · USD

24.98

0.00 (0.00%)

At close: Apr 26, 2023, 10:00 PM

Provention Bio Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017	Q3 2017	Q2 2017	Q1 2017	Q4 2016
Period Ending	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016
Net Income	-33.28M	-28.63M	-29.69M	-21.97M	-25.83M	-27.02M	-29.14M	-32.44M	-32.58M	-31.3M	-22.12M	-12.58M	-10.54M	-9.77M	-12M	-10.97M	-5.68M	-5.39M	-10.34M	-5.06M	-3.68M	-1.36M	-4.04M	-42.99K	-165K
Depreciation & Amortization	811K	144K	136K	137K	137K	96K	81K	73K	n/a	n/a	n/a	1K	-16K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Stock-Based Compensation	9.21M	3.3M	3.2M	3.31M	2.58M	3.13M	3.27M	2.86M	8M	2.71M	1.28M	1.24M	1.21M	923K	461K	244K	234K	393K	415.46K	98.54K	100.72K	48K	58K	n/a	n/a
Other Working Capital	15.27M	3.02M	-630K	-344K	-385K	-1.38M	-17K	12.12M	-712K	4.48M	-1.26M	416K	88K	1.36M	-1.45M	3.18M	-372K	-775K	809.49K	-1.57M	53.11K	163K	-198.99K	n/a	n/a
Other Non-Cash Items	-367K	72K	121K	138K	121K	57K	134K	189K	196K	65K	43K	n/a	4.39M	n/a	n/a	n/a	n/a	217K	4.2M	84K	2K	37K	3.49M	n/a	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	15.64M	1.15M	-2.21M	3.35M	-472K	-1.61M	-4.43M	12.83M	-249K	3.76M	3.03M	2.18M	-402K	-174K	1.57M	3.4M	-328K	-1.14M	770.19K	-1.11M	400.86K	186K	-109.99K	42.99K	165K
Operating Cash Flow	-7.97M	-23.97M	-28.44M	-15.03M	-23.46M	-25.35M	-30.09M	-16.49M	-24.63M	-24.76M	-17.77M	-9.17M	-9.74M	-9.02M	-9.97M	-7.33M	-5.78M	-5.92M	-4.96M	-5.99M	-3.18M	-1.09M	-609K	n/a	n/a
Capital Expenditures	-373K	-196K	-226K	n/a	-42K	6K	-675K	-250K	-759K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	31.1M	n/a	n/a	n/a	-25.53M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-53.9M	-49.18M	n/a	n/a	-38.96M	n/a	-3.93M	-12.4M	-4.04M	-15.62M	n/a	-9.05M	-46.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	18M	3.15M	n/a	9.6M	1.31M	12.9M	6.12M	4.82M	13M	13M	13M	16M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-15M	n/a	n/a	n/a	-31.1M	n/a	n/a	n/a	25.53M	-352K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-51.27M	-46.23M	-226K	9.6M	-37.69M	12.91M	1.52M	-7.83M	8.2M	-2.98M	13M	6.95M	-46.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	905K	114.69M	11.63M	2.15M	102.33M	n/a	n/a	102.38M	291K	287K	113.52M	194K	71K	62.85M	n/a	n/a	20K	60.01M	-681K	n/a	752.00	n/a	n/a	n/a	n/a
Financial Cash Flow	905K	114.69M	11.63M	2.15M	n/a	n/a	n/a	102.38M	291K	287K	113.52M	194K	71K	62.85M	n/a	n/a	20K	60.01M	n/a	n/a	752.00	n/a	n/a	n/a	n/a
Net Cash Flow	-58.34M	44.5M	-17.03M	-3.28M	-61.15M	-12.44M	-28.58M	78.06M	-16.14M	-27.45M	108.75M	-2.02M	-55.92M	53.83M	-9.95M	-7.33M	-5.76M	54.09M	-5.64M	-5.99M	-3.18M	-1.09M	-609K	n/a	n/a
Free Cash Flow	-8.35M	-24.16M	-28.66M	-15.03M	-23.5M	-25.34M	-30.77M	-16.74M	-25.39M	-24.76M	-17.77M	-9.17M	-9.74M	-9.02M	-9.97M	-7.33M	-5.78M	-5.92M	-4.96M	-5.99M	-3.18M	-1.09M	-609K	n/a	n/a